United States: Five Key Takeaways From FDA's Updated Draft Guidance On Biosimilars Promotion - Arnold & Porter
Wednesday, 8 May 2024 ()
On April 24, 2024, the U.S. Food and Drug Administration (FDA) released a revised draft guidance entitled "Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products...
|
||||
You Might Like |
||||
